CRP and obesity disorder: Therefore, in this study, we aimed (1) to explore the association between DPs and NPs with a clinical marker of systemic inflammation, namely C-reactive protein (CRP) (12), in the Australian population; and (2) to determine whether the association affected by gender, obesity and metabolic health status.